Business Information
The group’s principal activity is to develop products to treat neurological diseases, The group products include Andara (TM), OFS(TM), BrainGate System, and NeuroPort(TM) System. In the year 2006, the group acquired Andara (TM) Life Science, Inc. The group operates from the United States. The group’s revenue in the year 2006 was $1,680,035.
|
|
Name |
Title
|
Email
|
| Mark Carthy | Chmn. | N/A | | John Donoghue | Founder, Chief Scientific Officer, Dir. | N/A | | Kurt Kruger | CFO | N/A | | Christopher Flaherty | Exec. VP - Technology, Intellectual Property | N/A | | Daniel Geffken | Dir. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 1,680 | (12,278) | | 2005 | 1,059 | (9,326) | | 2004 | 1,537 | (7,091)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
